8-KOther Events

WELLTOWER INC. 8-K Report, Corporate Update (Dec 6, 2012)

Filed December 6, 2012For Securities:WELL

Summary

This Form 8-K filing by Health Care REIT, Inc. (now Welltower Inc.) reports on a modification to the insider trading plan of its Chairman, CEO, and President, George L. Chapman. The modification allows for the sale of a specified number of company common stock shares and the exercise of stock options within a revised timeframe, between December 5, 2012, and December 31, 2012. This action is taken under Rule 10b5-1 of the Securities Exchange Act of 1934, providing an affirmative defense against insider trading allegations by ensuring trades are pre-planned when the executive is not in possession of material non-public information. Investors should note that this filing primarily concerns the executive's personal trading plan rather than a significant corporate event or financial update. The details of the actual stock sales will be reported separately on Form 4 filings. The company's existing insider trading policy, modified in 2003, permits such pre-arranged trading plans.

Key Highlights

  • 1Modification of George L. Chapman's (Chairman, CEO, President) insider trading plan.
  • 2The plan allows for the sale of up to 26,527 shares of common stock and exercise of options.
  • 3An additional 6,513 shares of common stock can also be sold under the modified plan.
  • 4The trading period for these transactions is revised to December 5, 2012, through December 31, 2012.
  • 5The trading plan complies with SEC Rule 10b5-1, providing an affirmative defense against insider trading.
  • 6Actual sales under the plan will be reported on subsequent Form 4 filings.
  • 7The company's insider trading policy was updated in 2003 to permit such pre-arranged trading plans.

Frequently Asked Questions

The main purpose of this filing is to report a modification to the insider trading plan of George L. Chapman, the company's Chairman, CEO, and President, under SEC Rule 10b5-1. This plan allows him to sell company stock and exercise options within a specific timeframe.

No, this filing does not directly indicate any changes in the company's financial performance or outlook. It solely concerns the executive's personal stock trading plan, which is designed to comply with insider trading regulations.

Rule 10b5-1 provides an affirmative defense against insider trading allegations by allowing company insiders to set up pre-arranged trading plans. These plans must be established when the insider is not aware of material non-public information, ensuring that trades are based on a pre-determined strategy rather than current inside information.

The actual details of any sales made under this plan, including the number of shares and the prices, will be reported by Mr. Chapman on separate Form 4 filings with the SEC, as required by regulations.